The Power of Precision
Med Tech Gurus
What happens when clinical strategy, bioinformatics, and market access all live under one roof? Meet Tyler O’Malley, VP at Exagen, who shares how this rare triad is driving innovation in autoimmune diagnostics. In this episode, Tyler reveals how real-world data fuels product strategy, why storytelling is key to market access, and how diagnostic innovators can scale in a payer-driven world. We explore the evolution of evidence, the importance of physician advocacy, and how to align science with unmet clinical need—without chasing shiny objects. Gurus, if you're launching diagnostics or...
info_outline
Standardizing Behavioral Health from the Inside Out
Med Tech Gurus
Behavioral health is in crisis—not just from rising demand, but from the chaos of inconsistent care models, fragmented data, and outdated systems. In this episode of Med Tech Gurus, Jim Szyperski, CEO of Acuity Behavioral Health, shares how his team is bringing much-needed structure and accountability to inpatient psychiatric care. Backed by a $1.5 million seed round and in collaboration with health systems, Acuity is creating data-driven standards that empower nurses, improve patient outcomes, and deliver operational clarity. Jim brings lessons from decades of entrepreneurship and...
info_outline
The Immune Decoder: Cracking the Code of Long COVID
Med Tech Gurus
What if we could finally put real answers behind the brain fog, fatigue, and lingering symptoms so many patients still face post-COVID? In this episode, Dr. Nigel McCracken, Chief Operating Officer at Virax Biolabs, returns to Med Tech Gurus to reveal how their groundbreaking ViraxImmune platform is decoding the hidden dysfunctions of the immune system. With major NHS-led trials underway and U.S. clinical sites ramping up, Nigel shares how their proprietary FluoroSpot T-cell assay brings unprecedented accuracy to diagnosing long COVID, chronic fatigue, and post-viral syndromes. We also dive...
info_outline
Breaking the AI Bottleneck in Healthcare
Med Tech Gurus
Billions are being poured into healthcare AI, yet most innovations never make it past pilot projects. Why? And more importantly—how do we fix it? In this episode of Med Tech Gurus, we sit down with Marco Smit, serial entrepreneur, life sciences executive, and AI commercialization expert. With leadership experience at Roche, Genentech, Gesund.ai, CareSyntax, and now Domelabs.ai, Marco has seen the full spectrum of healthcare AI—from hype to hard-earned success. He shares why so many organizations fall victim to “pilotitis”, the critical role of AI governance, and how startups and health...
info_outline
Breaking Barriers
Med Tech Gurus
What if we could finally crack the code on treating brain cancer by opening the door that’s blocked 98% of therapies? In this episode, Dr. Michael Canney, Chief Scientific Officer of Carthera, reveals how SonoCloud—a revolutionary ultrasound implant—temporarily opens the blood-brain barrier to deliver chemotherapy directly to tumors like glioblastoma. With over 100 patients enrolled in a Phase III trial across 40 global sites, this isn’t just a bold idea—it’s happening now. Michael also shares real-world lessons in scaling trials, FDA navigation, and aligning science with...
info_outline
AI vs Burnout: How Affinion Health Is Reclaiming Time for Clinicians
Med Tech Gurus
What if the key to solving the provider burnout crisis wasn’t adding more hours in the day—but using technology to give them back? In this episode of Med Tech Gurus, we meet David Norris, Co-Founder and CEO of Affinion Health. David shares how his company is building an AI-powered clinical inbox that helps clinicians manage the overwhelming flood of lab results, patient messages, and admin tasks. With measurable results like five hours of reclaimed time per week per provider, David explains how Affinion’s solution is not just about efficiency—it’s about restoring balance, improving...
info_outline
The End of Guesswork: How AI and 3D Printing Are Reshaping Surgery
Med Tech Gurus
What if surgeons could eliminate the guesswork from complex procedures and walk into the OR with a personalized, pre-fitted solution ready to go? In this episode, we meet Vikram Ahuja, Co-Founder and CEO of OsseoLabs, who is transforming orthopedic and maxillofacial surgery using AI and 3D printing. Vikram reveals how his platform builds patient-specific implants using biomechanical data—dramatically reducing OR time, complications, and the need for revision surgeries. With over 170 successful cases and 40 hospital partners across Southeast Asia, Vikram shares what’s next, what’s needed...
info_outline
From Idea to Impact: A MedTech Masterclass
Med Tech Gurus
What turns a brilliant idea into a market-ready medical device? Jennifer Palinchik, CEO of SageMar Medical, has spent over two decades guiding innovators through that exact journey. In this episode, Jennifer shares the critical factors that determine whether your device gets adopted—or ends up on the shelf. From navigating regulatory hurdles and defining market value to aligning R&D with commercialization from day one, Jennifer reveals the strategic playbook that every MedTech founder should know. We also explore trends like AI, mixed reality, and the growing role of M&A in...
info_outline
Engineering the End of Radical Prostatectomy
Med Tech Gurus
Gurus, what if treating prostate cancer no longer required surgery, blood loss, or hospital stays? In this episode, we sit down with Dr. Arun Menawat, CEO of Profound Medical, who is leading a bold transformation in prostate cancer care. With Tulsa Pro—an AI-powered, MRI-guided, incision-free therapy—his team is challenging the surgical status quo head-on. Arun shares how his journey through imaging innovation shaped this breakthrough, and why he believes the future of interventional medicine will be bloodless, precise, and radically patient-centric. This one’s not just...
info_outline
Smarter, Safer, Faster: How AI is Rewiring the OR
Med Tech Gurus
What if your hospital could see, hear, and understand everything happening in the OR—and actually use that data to drive real-time improvements? Dr. Andrew Gostine, CEO and co-founder of Artisight, is making that vision a reality. With AI-powered computer vision and ambient listening, Artisight enables hospitals to automate documentation, reduce delays, and even prevent wrong-site surgeries. Now partnered with industry giants like NVIDIA and Karl Storz, Artisight is helping over 400 hospitals transform their perioperative workflows—enhancing safety, equity, and efficiency at scale. In this...
info_outlineBillions are being poured into healthcare AI, yet most innovations never make it past pilot projects. Why? And more importantly—how do we fix it?
In this episode of Med Tech Gurus, we sit down with Marco Smit, serial entrepreneur, life sciences executive, and AI commercialization expert. With leadership experience at Roche, Genentech, Gesund.ai, CareSyntax, and now Domelabs.ai, Marco has seen the full spectrum of healthcare AI—from hype to hard-earned success.
He shares why so many organizations fall victim to “pilotitis”, the critical role of AI governance, and how startups and health systems can build scalable, evidence-driven solutions that actually deliver ROI. From navigating the complex regulatory landscape to choosing the right investors and partners, Marco offers a pragmatic playbook for moving AI from the lab to real clinical impact.
Whether you’re a startup founder, health system innovator, or medtech investor, this episode is packed with actionable insights on avoiding hype, accelerating adoption, and building AI solutions that last.